SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-22-000041
Filing Date
2022-05-05
Accepted
2022-05-05 07:02:33
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnce-20220505.htm   iXBRL 8-K 39121
2 EX-99.1 q12022earningsrelease.htm EX-99.1 55939
6 cnceimagea01.jpg GRAPHIC 7277
  Complete submission text file 0001367920-22-000041.txt   254192

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20220505.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20220505_lab.xml EX-101.LAB 24791
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20220505_pre.xml EX-101.PRE 13056
8 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20220505_htm.xml XML 12032
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 22893970
SIC: 2834 Pharmaceutical Preparations